The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지

The Effects of Injinchunggantang-derivative on Cell Viability, Cell Cycle Progression and Apoptosis of Hepatocytes

인진청간탕가미방(茵陳淸肝湯加味方)이 간세포활성(肝細胞活性), 세포주기(細胞週期) 및 APOPTOSIS에 미치는 영향(影響)

  • Hong, Sang-Hoon (Department of 1st Internal Medicine, College of Oriental Medicine, Dong Eui University) ;
  • Lee, Jang-Hoon (Department of 1st Internal Medicine, College of Oriental Medicine, Kyung Hee University) ;
  • Woo, Hong-Jung (Department of 1st Internal Medicine, College of Oriental Medicine, Kyung Hee University)
  • 홍상훈 (동의대학교 한의과대학 간계내과학 교실) ;
  • 이장훈 (경희대학교 한의과대학 간계내과학교실) ;
  • 우홍정 (경희대학교 한의과대학 간계내과학 교실)
  • Published : 1998.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

To evaluate the effects of Injinchunggantang-derivative on cell viability, cell cycle progression, and apoptosis, MTT assay, cell cycle analysis, Cpp32 protease assay, DNA fragnemtation assay, quantitative RT-PCR, and Western blotting were performed. The results were as followes. In MTT assay, etoposide+Injinchunggantang-derivative-treated cells as well as Injinchunggantang-derivative-treated cells showed higher viability than etoposide-treated cells with no time-concentration-dependence, which implied that Injinchunggantang-derivative has hepato-protective effect Cell cycle analysis showed that Injinchunggantang-derivative has no significant effect on the cell cycle. Cpp32 protease assav and DNA fragmentation assay Injinchunggantang-derivative carry inhibitory effects on apoptosis induction. It was suggested that Injinchunggantang-delivative might regulate the cell cycle, in particular $G_1$ checkpoint by blocking p53 and Watl pathway. Injinchunggantang-derivative inhibited the mRNA expressions of Cpp32, Fas, and Bcl-2, which could result in inhibition of apoptosis. These results imply that Injinchunggantang-derivative increases hepatocyte viability, and protects hepatocyte from damage by regulating the expression of genes associated with cell cycle and apoptosis, which explains the mechanism of the clinical effect of Injinchunggantang-derivative on liver diseases.

Keywords

References

  1. 대한약전외 한약(생약)규격집 주해서 이상인;지형준
  2. 本草學 全國 韓醫科大學 本草學敎授
  3. 96年度 死亡原因統計結果 統計廳
  4. 茵陳淸肝湯加味方이 實驗的 흰쥐의 肝硬變症에 미치는 影響 姜京兌
  5. 중등도 또는 고도의 비호지킨 림프종에 대한 VACOP-B (Etoposide/Doxorubicin/Cyclophosphamide/Vincristine/Prednisolone/Bleomycin) 복합화학요법의 제 2상 연구 곽영임
  6. B 세포 림프종에서 bcl-2/IgH 재조합과 p53 및 c-myc 암단백의 검색 권기영
  7. The Graduate School of Kyung-hee University Cisplatin and Etoposide(VPP) Combination Chemo- therapy in Small Cell Lung Cancer Kwon soon in
  8. 파터씨 팽대부암의 예후인자와 p53, c-erbB-2, chromomgranin A, PCNA의 임상적 의의 김기환
  9. 大韓內科學會誌 v.49 no.2 Hep G2 肝癌細胞柱에서 Retinoic Acid가 p53 蛋白，Ki-67 및 PCNA/Cyclin發顯에 미치는 效果 김대곤;임수일;안득수
  10. 茵陳淸肝湯의 安全性에 關한 硏究 金榮哲
  11. J. Oriental Medicine v.1 no.1 Effects of Injinchunggantang on Fulminant Mouse Viral Hepatitis KIm jin joo
  12. The Korean Journal of Hepatology v.2 no.2 아포토시스와 간질환 김창민
  13. EXperimental and Modicine v.3 no.1 大韓 生化學 · 分子生物學會
  14. Korean J. Medicine v.48 no.4 위암종에서 p53 유전자 산물에 대한 면역조직화학적 연구 류도현;주영은;김태두;지미선;양대현;유종선;박창수;윤종만
  15. Molecular genetic Characterization of the the pathway of p53 Tumor suppressor gene in human stomach cancer 맹영희
  16. The effect of Inchinchunggantang-derivative on Prolife-ration of Hepatocyte Park yong Jin
  17. 세포의 열에 대한 반응시 생기는 생화학적 변화와 apoptosis에 관한 연구 박전의
  18. 第2回 韓·中 學術大會 參加論文集 -肝臟編－ 慢性B型肝炎에 대한 茵陳淸肝湯의 效果 禹弘楨
  19. The Kyung Hee Medicine v.13 no.3 A Study on the therapeutic effect of oriental medicine on Hepatitis B Hong Jung Woo;Jang Hun Lee;Young Chul Kim;Sang Man Kim;Sun Min Kim;Yong JIn Park;Sung Soo Kim;In Sug Kim;Joo hun Ha
  20. The Kyung Hee University Oriental Medical J. v.17 no.2 Effects of Samchil-Saenggan Tang on liver injury Hong jung Woo;Jang Hoon Lee
  21. 후두유두종에서 PCNA표현양상에 따른 예후추정 및 임상적 의의에 관한 연구 이동엽
  22. Introduction of APO-1 antigen expression by cytoxic agents and apoptosis in hepatoma cell line Lee sang mok
  23. 地楡의 抗세로토닌 作用 이소영
  24. 大韓內科學會誌 v.49 no.3 重合酵素 連鎖反應法을 利用한 Helicobacter pylori의 檢出 이준성;송동화;박찬욱;이문성;조성원;심찬섭;진소영
  25. 산화적 스트레스에 의한 Apoptosis의 유발과 항산화효소, 항산화제 및 항암제와의 관계 李志英
  26. 白朮類의 效能 比校 硏究 임강현
  27. 大韓內科學會誌 v.49 no.1 人體 大腸 上皮細胞및 大腸粘膜에 發顯된 여러 Cytokine 遺傳子의 定量分析을 通한 人體宿主 防禦機轉에 關한 硏究－合成 RNA를 利用한 定量的 逆轉寫 PCR法의 應用 정현채;김정목;송인성;김정룡
  28. 위장관 평활근 종양의 예후 지표로서 PCNA 면역조직화학염색의 유용성 최정환
  29. 상기도 및 폐의 원발성 암종과 유두종에서 중합효소 연쇄반응을 이용한 인유 두종바이러스 DNA의 검출 및 p53변이와의 상관관계에 관한 연구 홍은경
  30. 仲景全書 張仲景
  31. 金匱要略 張仲景
  32. 黃帝內徑素問今釋 王琦;李炳文;邱德文;王廣其;彭榮琛
  33. 本草備要解釋 楊東喜
  34. 新編中藥大辭典 新文豊出版公司(編)
  35. 本草綱目 李時珍
  36. Shen Nong Ben Cao Jing Xu shu nan;Niu bing zhan bian zhu
  37. J. of practical East-West Medicine v.10 no.2 Effect of the extract of Polyporus on Hepatitis B Ai-Xiu Nian
  38. J. Hepatology v.25 no.3 Regulation of Cyclin-Dependent Kinase Inhibitor p21$^{WAF1/Cipl/Sdil}$Gene Exp-ression in Hepatic Regeneration Albrech J. H.;Mayer A. H.;Humy m.Y.
  39. J. Biol. Chem v.271 no.28 Fas-induced Activation of the Cell Death-related Protease CPP32 is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors Armstrong R. C.;Aja T.;Xiang J.;Caur G.;Kerbs J. F.;Hoang K.;Bai X.;Korsmeyer S. J.;Karanewsky D. S.;Fritz L. C.;Tomaselli K. J.
  40. The FASEB J. v.11 no.7 p53 deficiency in liver reduce local of survival and proliferation, but does not affect apoptosis after DNA damage Bellamy C. O. C.;Clarke A. R.;Wyllie A. H.;Harrison D. J.
  41. Proc. Natl. Acad. Sci. v.87 no.5 abnormal structure and expression of p53 gen in human hepato-cellular carcinoma Bressac B;Galvin K. M;Liang T. J.;Isselbacher K. J;wands J. R;Ozturk M.
  42. Leuk Res. v.8 no.2 Review cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells Celis J. E.;Bravo R.;Larsent P.M.
  43. Cancer chemother Pharma-cology. v.17 no.3 Rapid chemosensitivity testing of human lung tumor cells using the MTT assay Cole S. P.
  44. The j. of biological chemistry v.272 no.3 Activation of a CrmA-insensitive, p53-sensitive pathway in ionizing radiation-induced apoptosis Datta R.;Kojima H.;Banach D.;Bump N.J.;Talanion R. V.;Alnemri E. S.;Weichselbaum R. R.;Wong W.W.;Kufe D.W.
  45. Proc. Natl. Acad. Sci. v.92 no.12 Transforming growth factor induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism Datto M. B.;Yan Li;Panus J. F.;Howe D. J.;Xiong Y.;Wang Xiao-Fan
  46. Cell v.75 no.4 WAF1, a potential mediator of p53 tumor suppression El-Deiry W. S.;Tokino-T.;Velcululesou-V. E.;Levy-V. E.;Parsons R.;Trent-J. M.;Lin. D.;Mercer-W. E.;Kinzler-K. W.;Vogelstein-B.
  47. Nature v.380 Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis Enari M.;Talanian R. V.;Wong W. W.;Nagata S.
  48. Cell v.73 no.3 Functional interactions of the retino-blastoma protein with mammalian D-type cyclins Ewen M. E.;Sluss H. K.;Sherr C. J.;Matsushime H. Kato J.;Livingston D. M.
  49. J. Bio. Chem v.269 no.49 CPP32, a Novel human Apoptotic protein with Homology caenor-haditis elegan cell Death protein Ced-3 and Mommalian Interleukin-1 ${\beta}$-converting Enzyme Fernandes-Alnemri T.;Litwack G.;Alnemri E. S.
  50. PCR Methods and Applications v.2 Quantitaive or semi-quantotative PCR : reality versus myth Ferre F.
  51. Blood v.98 no.8 Expression and regulation of Bcl-2, Bcl-${_XL}$, Bax correlate with o53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia Findly H. W.;Gu L.;Yeager A. M.;Zhou M.
  52. The J. of Biol. Chem v.271 no.45 Transcriptional Activation of the cdc2 Gene Is Associated with Fas-induced Apoptosis of Human Hematopoetic Cells Furugwa Y.;Iwase S.;Terui Y.;Kikuchi J.;Sakai T.;Nakamura M.;Kikuchi J.;Sakai T.;Nakamura M.
  53. Proc Natl. Acad Sci. v.88 no.22 Wild-type p53 can down-modulate the activity of various promoters Ginsberg D.;Mechta F.;Yaniv M.;Oren M.
  54. J. Hepatology v.26 no.6 Enhanced Apoptosis Relates to Bile Duct Loss in Primary Biliary Cirrhosis Harada K.;Ozaki S.;Gershwin M. E.;Nakamura Y.
  55. Cancer Res. v.55 Mutant p53 but not Hepatitis B Virus X Protein Is present in Hepatitis B Virus related Human Hepatocellular Carcinoma Henkler F.;Waseem N.;Golding M. H. C.;Alison M. R.;Koshy R.
  56. J. Hepatology v.19 no.6 Immunohistochemical detection of Fas antigen in liver tissue of patiens with chronic hepatitis C Hiramatsu N.;Hayashi N.;Katayama K.;Mochizuki K;Kawanishi Y.;Kasahara A.;
  57. J. Hepatlolgy v.21 Fulminant failure : Summary of a workshop Hoofnagle J.;Carithers R.;Shapiro C.;Ascher N.
  58. J Hepatology v.25 no.3 Reduced p21$^{WAFl/CIPl} Expression and p53 Mutation Hepatocellular Carcinoma Hui A. M.;Kanai Y.;Sakamoto M.;Tsuda H.;Hirohashi S.
  59. Journal of Pediatric surgery v.30 no.6 Bcl-2 Oncoprotein Expression and apoptosis in neuroblastoma Ikeda H.;Hirato J.;Akami M.;Matsuyama S.;Suzuki N.;Takahashi A.;Kuroiwa M.
  60. The journal of immunology v.151 no.2 Effect of bcl-2 on Fas antigen-mediated cell death Itoh N.;Tsujimoto Y.;Nagata S.
  61. Cell v.88 Programmed cell death in animal development Jacobson M. D.;Weil M.;Raff M. C.
  62. Science(Washinton DC) v.256 Oncogenic forms of p53 inhibit p53-regulated gene expression Kern S. E.;Pietenpol J. A.;Thialingam S.;Seymour A.;Kinzler K. W.;Vogelstein B.
  63. J. Hepatology v.25 no.5 Nuclear DNA Fragmentation and Expression of Bcl-2 in Primary Biliary Cirrhosis Koga H.;Sakisaka S.;Ohishi M.;Sato M.;Tanikow K.
  64. Bri. J Hema v.99 mRNA expression of Fasreceptor(CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-asso-ciating protein with death domein/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell line Komada Y,;Inaba H.;Zhou Y. W.;Zhang X. L., Z.Tanaka S.;Azuma E.;Sakuri M.
  65. Can. Res. v.57 Immunohistochemical Analysis of in Vivo Patterns of Expression of CPP32 (Caspase-3) , a Cell Death Protease. Krajewska M.;Wang H. G.;Krajewski S.;Zaoata J. M.;Shabaik A.;Gascoyne R.;Reed J. C.
  66. Nature v.384 Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice Kuida K.;Zheng T. S.;Na S.;Kuan Chia-yi.;Yang D.;Karasuyama H.;Rakic P.;Flavell R. A.
  67. Ame Physi. Soc. Hepathocytes in the bile duct- ligated rat express Bcl-2 Kurosawa H.;Que F. G,;Roberts L. R.;Fesmior P. J.;Gores G. J.
  68. Nature v.278 T antigen is bound to a host protein in SV40-trans-formed cells Lane D. P.;Crawford L. V.
  69. Nature v.379 Interaction of Cdc2 and Cdc18 with a fission yeast ORC2-like protein Leatherwood J.;Lopez-Girona A.;Russel P.
  70. Gastroenterology v.112 Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins Leist M.;Gartner F.;Naumann H.;Bluthmann H.;Voget K.;Brigelrus-Flohe R.;Nicotera P.;Volk H. D.;Wendel A.
  71. Proc. Natl. Acad. Sci. v.91 no.21 Constitutive expression of B-myb can bypass p53-induced Wafl/CiPl-mediated G$_1$ arrest Lin D.;Fiscella M.;O'Connor P. O.;Jackman J. J.;Chen C.;Luo Ling L.;Sala A.;Travali S.;Appella E.;Mercer E.
  72. Blood v.88 no.10 Flt3 ligand stimulates proliferation and inhibits apoptosis of acut myeloid leukemia Cells : Regulation of Bcl-2 and Bax Lisovsky M.;Estrov Z.;Zhang X.;Consoil U.;Sanchez－Williams G.;Snell V.;Munker R.;Goodacre A.;Savchenko V.;Andreeff M.
  73. Cancer v.71 no.15 The prognostic significance of the proliferating nuclear antigen, epidermal growth factor receptor and mdr gene expression in colorectal cancer Mayer A.;Takimato M.;Fritz E.;Schellander G.;Kofler K.;Ludwig M.
  74. Cancer Res. v.54 no.13 Induction of WAFl/CIPl by a p53-independent pathway Michieli P.;Chedid M.;Lin D.;Pierce J. H.;Mercer W.;Givol D.
  75. J. Hepatology v.24 Fas antigen expression in liver tissues of patients with chronic hepatitis B Mochizuki K.;Hayashi N.;Hiramatsu N.;Katayama K.;Kawanishi K.;Kasahara A.;Fusamoto H.;Kamada T.
  76. Journal of immunologic methods v.65 no.1-2 Rapid colorimetric assay for cellular growth and survival : application to proliferation and cytotoxicity assays Mosmann T
  77. Natuer v.364 Lethal effect of the anti-Fas antibody in mice Ogasawara J.;Watanabe-Fukunaga R.;Adachi M.;Matsuzawa A.;Kasugai T.;Kitamura Y.;Itoh N.;Suda T.;Nagata S.
  78. Proc. Natl. Acad. Sci. USA v.94 no.7 Cell cycle independent interaction of CDC2 with the nuclear matrix-intermediate filament scaffold Pockwinse S. M.;Krockmalnic G.;Doxsey S. J.;Nickkerson J. N.;Lian J. B.;Wijnen A. J.;Stein J. L.;Stain G. S.;Penman S.
  79. Bio. and Biophy. Res. COM. v.229 Mutiple Pathways of Fas-induced Apoptosis in primary Culture of Hepatocytes Rouquet N.;Carlier K.;Briand P.;Wiels J.;Joulin V.
  80. Cell v.58 no.5 Oncogenic ras provokes premature ce1l senescence associated with accumulation of p53 and p16$^{INK/4a} Sarranto M.;Lin A. W,;Mccurrach M. E.;Beach D.;Lowe S. W.
  81. Bioche. and Biophy. Res. Com v.28 no.3 P21$^{WAF-1/cip-1/sdi-1} Is Expressed at G$_1$ Phase in Primary Culture of Hepatocytes from Old Rats, Presumably Preventing the cell from Entering the S Phase of the Cell Cycle Sawada N.;Kozima T.;Obata H.;Saitoh M.;Isomura H.;Kokai Y.;Satoh M.;Mori M.
  82. proc. natl. Acad. Sci. USA v.94 no.21 Comparison of the ion channol characteristics of proapoptotic BAX and antiapoptotic BCL-2 Schlesinger P. H.;Gross A.;Yin A. M.;Yamamoto K.;Saito M.;Waksman G.;Korsmeyer S. J.
  83. Trends. Biol. Sci. D-type cyclins Sherr C. J.
  84. Proc. Natl. Acad. Sci. USA v.93 BAX enhances paclitaxel-induced apoptosis through a p53-independent Pathway Strobel T.;Swanson L.;Korsmeter S.;Cannistra S. A.
  85. Blood v.88 no.5 Upregulated Expression of Bcl-2 in multiple myeloma cells induced by exposure to Doxorubicin, Etoposide, and Hydrogen Peroxide Tu Y.;Feng-hao Xu.;Jin Liu;Versco R.;Berenson J.;Fady C.;Lichtanstein A.
  86. Am. J. Path. v.150 no.6 Expression of Bcl-2 Family during Liver Regeneration and Identifica-tion of Bcl-x as a Delayed Early Response Gene Tzuing S. P.;Fausto N.;Hockenbery D. M.
  87. Nature v.369 The p21 inhibitor of cyclin-dependent kinase nomal controls DNA replication by interaction with PCNA Waga S.;Hannon G.J.;Beach D.;Stillman, B.
  88. Proc. Natl. Acad Sci. USA. v.86 no.24 Quantitation of mRNA by polymerase chain reaction. Wang A. M. W.;Doyle M. V.;Mark D. F.
  89. Br. J. Cancer v.67 Apoptosis Wyllie A. H.
  90. The Ame. Physi. Soc. Cyclin D1 is required for S phase traversal in bovine trachel myocytes Xiong W.;Pestell R. G.;Watanabe G.;Li J.;Rosner M. R.;Hershenson M. B.
  91. Nature v.366 P21 is a universal inhibitor of cyclin Kinase Xiong Y.;Hannon G. J.;Zang H.;Casso D. Kobayashi R.;Beach D.
  92. Transplant proc v.29 no.1-2 Prevention of Hypoxic Liver Injury by In Vivo Transfecion of the Human bcl-2 Gene Yamabe K.;Kamiike W.;Shimizu S.;Wagurk S.;Hasegawa J.;Okuno S.;Yoshioka Y.;Sawa Y.;Uchiyama Y.;Matsuda H.
  93. J. Bio. Chem v.272 no.13 The Molecular Interaction of Fas and FAP-1 Yanagisawa J.;Takahashi M.;Kanki H.;Yano-Yanagisawa H.;Tazunoki T.;Sawa E.;Nishitoba T.;Kannishohara M.;Kobayashi E.;Kataoka S.;Sato T. S.
  94. nature v.385 Bax suppresses tumorigenesis and stimulates apoptosis in vivo Yin C.;Knudson C. M.;Korsmeyer S. J.;Van-Dyke T.